Healthcare - Biotechnology - NASDAQ - US
$ 0.569
2.89 %
$ 65.7 M
Market Cap
-0.65
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
55.68%
Net Income
Estimate
29.19%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
AlloVir, Inc.
ALVR has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ALVR
EBIT FORECAST
EBIT Forecast Chart ALVR
NET INCOME FORECAST
Net Income Chart ALVR